tagraxofusp

A drug used to treat a rare blood cancer called blastic plasmacytoid dendritic cell neoplasm. It is also being studied in the treatment of other types of cancer. Tagraxofusp is made up of interleukin-3 (IL-3), which binds to an IL-3 receptor protein called CD123. CD123 may be found in higher than normal amounts on some types of cancer cells. Tagraxofusp is also made up of a diphtheria toxin, which may help kill cancer cells. Tagraxofusp is a type of cytotoxin. Also called Elzonris.